Medtronic plc (NYSE:MDT) is in talks to acquire Israeli insulin pump patch developer Triple Jump Israel Ltd. at a company valuation of $300 million. Triple Jump's small insulin pump patch for diabetes patients is designed to be placed on the patient’s body. The patch has mobile connectivity capabilities and will be included in a future artificial pancreas system - Medtronic has already developed such an artificial pancreas system and plans integrating Triple Jump's device into the system to improve its pumping capabilities.